Skip to content
10-Q

Quarterly Report

ESSA Pharma Inc.

0001558370-25-006850

← back to feed
Filed
May 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · May 7, 2025 44.39M sh
Shares Diluted Q2 2025 · Mar 31, 2025 44.39M sh
Shares Diluted Q2 2025 · Mar 31, 2025 44.39M sh
Shares Diluted Q2 2025 · Mar 31, 2024 44.24M sh
Shares Diluted Q2 2025 · Mar 31, 2024 44.18M sh
Operating Cash Flow Q2 2025 · Mar 31, 2025 −$13.32M
Operating Cash Flow Q2 2025 · Mar 31, 2024 −$13.6M
Short Term Investments Q2 2025 · Mar 31, 2025 $27.56M
Short Term Investments Q2 2025 · Sep 30, 2024 $23.05M
Cash And Equivalents Q2 2025 · Mar 31, 2025 $86.31M
Cash And Equivalents Q2 2025 · Sep 30, 2024 $103.71M
Stockholders Equity Q2 2025 · Mar 31, 2025 $113.55M
Stockholders Equity Q2 2025 · Dec 31, 2024 $118.77M
Stockholders Equity Q2 2025 · Sep 30, 2024 $124.61M
Stockholders Equity Q2 2025 · Mar 31, 2024 $133.47M
Stockholders Equity Q2 2025 · Dec 31, 2023 $140.68M
Stockholders Equity Q2 2025 · Sep 30, 2023 $145.63M
Current Liabilities Q2 2025 · Mar 31, 2025 $1.71M
Current Liabilities Q2 2025 · Sep 30, 2024 $3.3M
Total Liabilities Q2 2025 · Mar 31, 2025 $1.87M
Total Liabilities Q2 2025 · Sep 30, 2024 $3.51M
Current Assets Q2 2025 · Mar 31, 2025 $115.17M
Current Assets Q2 2025 · Sep 30, 2024 $127.56M
Total Assets Q2 2025 · Mar 31, 2025 $115.42M
Total Assets Q2 2025 · Sep 30, 2024 $128.11M
Eps Diluted Q2 2025 · Mar 31, 2025 −$0.14
Eps Diluted Q2 2025 · Mar 31, 2025 −$0.34
Eps Diluted Q2 2025 · Mar 31, 2024 −$0.20
Eps Diluted Q2 2025 · Mar 31, 2024 −$0.34
Eps Basic Q2 2025 · Mar 31, 2025 −$0.14
Eps Basic Q2 2025 · Mar 31, 2025 −$0.34
Eps Basic Q2 2025 · Mar 31, 2024 −$0.20
Eps Basic Q2 2025 · Mar 31, 2024 −$0.34
Sga Expense Q2 2025 · Mar 31, 2025 $3.9M
Sga Expense Q2 2025 · Mar 31, 2025 $8.11M
Sga Expense Q2 2025 · Mar 31, 2024 $4.32M
Sga Expense Q2 2025 · Mar 31, 2024 $6.53M
Rd Expense Q2 2025 · Mar 31, 2025 $3.48M
Rd Expense Q2 2025 · Mar 31, 2025 $8.96M
Rd Expense Q2 2025 · Mar 31, 2024 $6.18M
Rd Expense Q2 2025 · Mar 31, 2024 $11.55M
Net Income Q2 2025 · Mar 31, 2025 −$6.37M
Net Income Q2 2025 · Mar 31, 2025 −$14.91M
Net Income Q2 2025 · Mar 31, 2024 −$8.99M
Net Income Q2 2025 · Mar 31, 2024 −$14.95M